Refine
Year of publication
Document Type
- Article (48)
- Preprint (7)
- Working Paper (1)
Has Fulltext
- yes (56)
Is part of the Bibliography
- no (56)
Keywords
- ADHD (6)
- bipolar disorder (4)
- Bipolar disorder (3)
- Aspergillus fumigatus (2)
- COVID-19 (2)
- Genetics (2)
- attention (2)
- continuous performance test (2)
- hyperactivity (2)
- impulsivity (2)
- polygenic risk score (2)
- 16p11.2 (1)
- 2030 Agenda (1)
- ADHD differential diagnosis (1)
- AML (1)
- ARDS (1)
- Accidents (1)
- Affective disorders (1)
- Amphetamine (1)
- Atomoxetine (1)
- Attention (1)
- Autism (1)
- Biodiversity (1)
- Biomarker (1)
- CRISPR/Cas9 (1)
- CVID (1)
- Cognitive dysfunction (1)
- Consensus (1)
- Conservation biology (1)
- Critical care (1)
- Depression (1)
- Diagnostic markers (1)
- Diagnostic test (1)
- Differential diagnosis (1)
- EBM (1)
- Electron-pion identification (1)
- Environmental impact (1)
- European Society for Immunodeficiencies (ESID) (1)
- Evidence-based (1)
- Evidenzbasierung (1)
- Fibre/foam sandwich radiator (1)
- GHQ-28 (1)
- Genome-wide association studies (1)
- German PID-NET registry (1)
- Guidelines (1)
- HDAC (1)
- HDACi (1)
- Heuristic (1)
- IgG substitution therapy (1)
- Immune response (1)
- Immunity (1)
- Immunogenetics (1)
- Immunology (1)
- Immunology and Microbiology Section (1)
- Injuries (1)
- Ionisation energy loss (1)
- Konsens (1)
- Kynurenine (1)
- Leitlinien (1)
- Lithium (1)
- MYC (1)
- Maintenance treatment (1)
- Mania (1)
- Methylphenidate (1)
- Monitoring (1)
- Multi-wire proportional drift chamber (1)
- Multiplex immunoassay (1)
- Nesplora Aquarium (1)
- Neural network (1)
- Non-linear cost (1)
- Normative dimension (1)
- Outcome (1)
- PARK2 (1)
- PCR (1)
- PID prevalence (1)
- Pandemic (1)
- Polarity index (1)
- Postvention (1)
- Predominant polarity (1)
- Prize-collecting (1)
- Prognostic models (1)
- Psychiatric disorders (1)
- Qb-Test (1)
- QbTest® (1)
- Quinolinate phosphoribosyltransferase (1)
- Quinolinic acid (1)
- Randomized controlled trial (1)
- Renal replacement therapy (1)
- SARS-CoV-2 (1)
- Schizophrenia (1)
- Science–society interactions (1)
- Sholl analysis (1)
- Stimulant (1)
- Suicidal behavior (1)
- Suicidal thoughts (1)
- Suicidality (1)
- Suicide (1)
- Suizidalität (1)
- Sustainability research (1)
- TR (1)
- Tracking (1)
- Trajectories (1)
- Transition radiation detector (1)
- Trigger (1)
- UPPS (1)
- Vehicle routing (1)
- Viral infection (1)
- WT1 (1)
- Working memory capacity (1)
- Xenon-based gas mixture (1)
- accidents (1)
- adult attention deficit/hyperactivity disorder (adult ADHD) (1)
- affective disorder (1)
- affective disorders (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- antisynthetase antibodies (1)
- antisynthetase syndrome (1)
- arthritis (1)
- attention deficit hyperactivity disorder (1)
- attention-deficit/hyperactivity disorder (1)
- biomarker (1)
- blood (1)
- body mass index (1)
- ceramides (1)
- cholangiocarcinoma (1)
- common variant (1)
- cross-sectional study (1)
- cytokine (1)
- dE/dx (1)
- depression (1)
- diabetes mellitus (1)
- disease modelling (1)
- early recognition (1)
- ectosomes (1)
- endocannabinoids (1)
- epigenetics (1)
- ex-Gaussian analysis (1)
- exosomes (1)
- extracellular vesicles (1)
- gene expression (1)
- genetic phenotypes (1)
- gene×environment interactions (1)
- geriatric medicine (1)
- glucose metabolism (1)
- guidelines (1)
- hematopoietic stem cell transplantation (1)
- hiPSC (1)
- human natural killer cell (1)
- immunohistochemistry (1)
- immunotherapy (1)
- indomethacin (1)
- interoperability (1)
- interstitial lung disease (1)
- machine learning (1)
- major depression (1)
- major depression (MD) (1)
- major depressive disorder (MDD) (1)
- mesenchymal stromal cells (1)
- metabolic syndrome (1)
- microparticles (1)
- microsatellite instability (1)
- microvesicles (1)
- minimal information requirements (1)
- mitochondria (1)
- molecular marker (1)
- myositis (1)
- naturalistic sample (1)
- neuropsychology (1)
- obesity (1)
- perforin (1)
- phagocytosis (1)
- pharmacogenetics (1)
- prediabetes (1)
- primary immunodeficiency (PID) (1)
- proteome (1)
- psychosocial stress (1)
- rare variant (1)
- registry for primary immunodeficiency (1)
- reproducibility (1)
- rigor (1)
- risk genes (1)
- smart home (1)
- smart living (1)
- standardization (1)
- substance abuse disorder (1)
- tandem mass spectrometry (1)
- venturesomeness (1)
- web of things (1)
- β-catenin (1)
Institute
Single nucleotide polymorphisms (SNPs) in the ADGRL3 gene have been significantly associated with the development of ADHD, the aetiology of which remains poorly understood. The rs1397547 SNP has additionally been associated with significantly altered ADGRL3 transcription. We therefore generated iPSCs from two wild type ADHD patients, and two ADHD patients heterozygous for the risk SNP. With this resource we aim to facilitate further investigation into the complex and heterogenous pathology of ADHD. Furthermore, we demonstrate the feasibility of using magnetic activated cell sorting to allow the unbiased selection of fully reprogrammed iPSCs.
Background: Predicted increases in suicide were not generally observed in the early months of the COVID-19 pandemic. However, the picture may be changing and patterns might vary across demographic groups. We aimed to provide a timely, granular picture of the pandemic's impact on suicides globally.
Methods: We identified suicide data from official public-sector sources for countries/areas-within-countries, searching websites and academic literature and contacting data custodians and authors as necessary. We sent our first data request on 22nd June 2021 and stopped collecting data on 31st October 2021. We used interrupted time series (ITS) analyses to model the association between the pandemic's emergence and total suicides and suicides by sex-, age- and sex-by-age in each country/area-within-country. We compared the observed and expected numbers of suicides in the pandemic's first nine and first 10-15 months and used meta-regression to explore sources of variation.
Findings: We sourced data from 33 countries (24 high-income, six upper-middle-income, three lower-middle-income; 25 with whole-country data, 12 with data for area(s)-within-the-country, four with both). There was no evidence of greater-than-expected numbers of suicides in the majority of countries/areas-within-countries in any analysis; more commonly, there was evidence of lower-than-expected numbers. Certain sex, age and sex-by-age groups stood out as potentially concerning, but these were not consistent across countries/areas-within-countries. In the meta-regression, different patterns were not explained by countries’ COVID-19 mortality rate, stringency of public health response, economic support level, or presence of a national suicide prevention strategy. Nor were they explained by countries’ income level, although the meta-regression only included data from high-income and upper-middle-income countries, and there were suggestions from the ITS analyses that lower-middle-income countries fared less well.
Interpretation: Although there are some countries/areas-within-countries where overall suicide numbers and numbers for certain sex- and age-based groups are greater-than-expected, these countries/areas-within-countries are in the minority. Any upward movement in suicide numbers in any place or group is concerning, and we need to remain alert to and respond to changes as the pandemic and its mental health and economic consequences continue.
Background: MDM2 inhibitors are under investigation for the treatment of acute myeloid leukaemia (AML) patients in phase III clinical trials. To study resistance formation to MDM2 inhibitors in AML cells, we here established 45 sub-lines of the AML TP53 wild-type cell lines MV4-11 (15 sub-lines), OCI-AML-2 (10 sub-lines), OCI-AML-3 (12 sub-lines), and SIG-M5 (8 sub-lines) with resistance to the MDM2 inhibitor nutlin-3.
Methods: Nutlin-3-resistant sub-lines were established by continuous exposure to stepwise increasing drug concentrations. The TP53 status was determined by next generation sequencing, cell viability was measured by MTT assay, and p53 was depleted using lentiviral vectors encoding shRNA.
Results: All MV4-11 sub-lines harboured the same R248W mutation and all OCI-AML-2 sub-lines the same Y220C mutation, indicating the selection of pre-existing TP53-mutant subpopulations. In concordance, rare alleles harbouring the respective mutations could be detected in the parental MV4-11 and OCI-AML-2 cell lines. The OCI-AML-3 and SIG-M5 sub-lines were characterised by varying TP53 mutations or wild type TP53, indicating the induction of de novo TP53 mutations. Doxorubicin, etoposide, gemcitabine, cytarabine, and fludarabine resistance profiles revealed a noticeable heterogeneity among the sub-lines even of the same parental cell lines. Loss-of-p53 function was not generally associated with decreased sensitivity to cytotoxic drugs.
Conclusion: We introduce a substantial set of models of acquired MDM2 inhibitor resistance in AML. MDM2 inhibitors select, in dependence on the nature of a given AML cell population, pre-existing TP53-mutant subpopulations or induce de novo TP53 mutations. Although loss-of-p53 function has been associated with chemoresistance in AML, nutlin-3-adapted sub-lines displayed in the majority of experiments similar or increased drug sensitivity compared to the respective parental cells. Hence, chemotherapy may remain an option for AML patients after MDM2 inhibitor therapy failure. Even sub-lines of the same parental cancer cell line displayed considerable heterogeneity in their response to other anti-cancer drugs, indicating the need for the detailed understanding and monitoring of the evolutionary processes in cancer cell populations in response to therapy as part of future individualised treatment protocols.
An integrative correlation of myopathology, phenotype and genotype in late onset Pompe disease
(2019)
Aims: Pompe disease is caused by pathogenic mutations in the alpha 1,4‐glucosidase (GAA) gene and in patients with late onset Pome disease (LOPD), genotype–phenotype correlations are unpredictable. Skeletal muscle pathology includes glycogen accumulation and altered autophagy of various degrees. A correlation of the muscle morphology with clinical features and the genetic background in GAA may contribute to the understanding of the phenotypic variability.
Methods: Muscle biopsies taken before enzyme replacement therapy were analysed from 53 patients with LOPD. On resin sections, glycogen accumulation, fibrosis, autophagic vacuoles and the degree of muscle damage (morphology‐score) were analysed and the results were compared with clinical findings. Additional autophagy markers microtubule‐associated protein 1A/1B‐light chain 3, p62 and Bcl2‐associated athanogene 3 were analysed on cryosections from 22 LOPD biopsies.
Results: The myopathology showed a high variability with, in most patients, a moderate glycogen accumulation and a low morphology‐score. High morphology‐scores were associated with increased fibrosis and autophagy highlighting the role of autophagy in severe stages of skeletal muscle damage. The morphology‐score did not correlate with the patient's age at biopsy, disease duration, nor with the residual GAA enzyme activity or creatine‐kinase levels. In 37 patients with LOPD, genetic analysis identified the most frequent mutation, c.‐32‐13T>G, in 95%, most commonly in combination with c.525delT (19%). No significant correlation was found between the different GAA genotypes and muscle morphology type.
Conclusions: Muscle morphology in LOPD patients shows a high variability with, in most cases, moderate pathology. Increased pathology is associated with more fibrosis and autophagy.
The prize-collecting vehicle routing problem with single and multiple depots and non-linear cost
(2013)
In this paper, we propose a new routing problem to model a highly relevant planning task in small package shipping. We consider the Prize-Collecting Vehicle Routing Problem with Non-Linear cost in its single and multi-depot version, which integrates the option of outsourcing customers to subcontractors instead of serving them with the private fleet. Thereby, a lower bound on the total customer demand to be served by the private fleet guarantees a high utilization of the fleet capacity. To represent the practical situation, where a discount is given by a subcontractor if larger amounts of packages are outsourced, subcontracting costs follow a non-linear function. The considered problem is NP-hard and we propose an Adaptive Variable Neighborhood Search algorithm to solve instances of realistic size. We propose new benchmark sets for the single and the multi-depot problem, which are adapted from test instances of the capacitated VRP and the closely related Multi-Depot VRP with Private fleet and Common carrier. In numerical studies, we investigate the performance of our algorithm on the newly generated test instances and on standard benchmark problems of related problems. Moreover, we study the effect of different cost functions and different values of the minimal demand to be served by the private fleet on the routing solutions obtained.